IDLDX — IDL Diagnostics AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK78.32m
- SEK55.16m
- SEK53.11m
Brief: AroCell's Patent Gets Approved On US Market
Brief: Nomination Committee Proposes Max Pihlqvist As Chairman Of Board In AroCell
Brief: Arocell Q4 Loss After Financial Items Amounted Widens To SEK 17.1 Mln
Brief: Ellen Dittberner Arocell's CFO Takes Parental Leave,
Brief: AroCell Obtains Regulatory Approval For TUBEX TF In Ethiopia
Brief: Arocell Loss After Financial Items SEK 13.0 Mln
Brief: AroCell Q3 EBIT SEK -13.265 Million
Brief: Arocell Posts Positive Sales Growth Of Rapid Tests
Brief: AroCell Q2 Revenue at SEK 11.775 Million
Brief: Arocell Says New Study Shows Clinical Benefit Of UBC Rapid In Detection Of Invasive Bladder Cancer
Brief: Arocell Signs Additional Agreement With Zecen Biotech
Brief: AroCell: TPS CLIA Receives Approval For Use On Fosun Diagnostics' Fully Automated System In China
Brief: AroCell Q1 Revenue at SEK 11.1 Million
Brief: Arocell Q1 Loss After Financial Items SEK 13.7 Mln
Brief: AroCell Improves Early Detection Of Ovarian Cancer With Algorithm
Brief: Arocell Q4 Net Sales Rise To SEK 12.5 Mln
Brief: AroCell Signs Distribution Agreement In Ethiopia
Brief: AroCell Provides Strategic Update
Brief: Arocell Q3 Loss After Financial Items Narrows To SEK 11.1 Mln